Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BiltRx vs Measured

By GLP-1 ScorecardUpdated

BiltRx
Site position #59

Higher grade

Measured
Site position #156

Lower grade

Score comparison

BiltRx has the higher recorded score — 75.3/100 to 68.7/100.

BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBiltRx +5
91
86
Dose & formulationBiltRx +8
85
77
Clinical oversightBiltRx +19
74
55
Labs & monitoringMeasured +11
52
63
FulfillmentBiltRx +4
71
67
Contract termsBiltRx +14
55
41
BiltRx · top barMeasured · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBiltRxMeasured
WeighScore75.3/10068.7/100
GradeCC
Site position#59#156
Semaglutide$125/mo (all doses, compounded)$119/mo (compounded)
Tirzepatide$129/mo (all doses, compounded)$219/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
BiltRx

Site position #59 · C

Strengths

  • Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
  • LegitScript verified and HIPAA compliant
  • Names its 503A compounding pharmacies (Boothwyn and Southend)
  • Offers both compounded and brand-name GLP-1 options

What to consider

  • Covered states are behind a check-availability gate, not listed
  • Starting prices may rise depending on plan and dose
Measured

Site position #156 · C

FDAWarning letter issued to Better Health Labs, Inc. dba Measured in February 2026. See the FDA warning-letter database.

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

What to consider

  • The headline $79 'GLP-1 Microdose' is a promotional rate off a $99 list price, is filed by the provider under longevity rather than weight loss, and is not a labeled therapeutic dose of either molecule
  • Branded plans are a $49/mo membership with the medication billed separately at $149 to $449/mo
  • The site never states which billing term its 'from' prices assume, though the terms allow monthly, quarterly, semi-annual and annual
  • No state count is published
  • FDA issued Better Health Labs, Inc. dba Measured a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard